Biologics Outsourcing Market
Biologics Outsourcing Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biologics Outsourcing Market Size and Growth
The Biologics Outsourcing market is experiencing robust growth due to increasing demand for customized therapies and cost-effective solutions. Current market size estimates exceed USD 200 billion, driven by advancements in biotechnology and an expanding pipeline of biologic drugs. This trend is expected to continue as more companies adopt outsourcing strategies.
Companies Covered
(Covid 19 Impact Covered)
◍ Boehringer Ingelheim
◍ Catalent
◍ GenScript
◍ Innovent Biologics
◍ Syngene
◍ Shanghai Medicilon
◍ GL Biochem Corporation
◍ GVK Biosciences Private
◍ Horizon Discovery Group
◍ Selexis
◍ Lonza
◍ Abzena
◍ Adimab
The Biologics Outsourcing Market features key players like Boehringer Ingelheim, Catalent, and Lonza, providing contract development and manufacturing services. These companies enhance market growth through advanced technologies, cost-efficiency, and expertise in biologics. Notable sales figures include:
- Boehringer Ingelheim: Approximately $22 billion
- Catalent: About $3 billion
- Lonza: Roughly $5 billion
Request Sample Report
Market Segmentation
By Application
By Product
Others ◍ Vaccine & Therapeutics Development ◍ Blood & Blood Related Products Testing ◍ Cellular and Gene Therapy ◍ Other
◍ Antibody
Recombinant
Protein
Vaccines
Request Sample Report
$ 1529.52 Million
Request Sample Report
